Q1 2024 Earnings Call Transcript May 14, 2024 Operator: Good afternoon, everyone. And welcome to the NRx Pharmaceuticals, Inc. First Quarter of 2024 Results Conference Call [Operator Instructions]. As ...

Significant financial improvements and advances in clinical trials mark NRX Pharmaceuticals Inc's first quarter of 2024.

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, a U.S. law firm, announced on Monday its acquisition of a life sciences patent ...

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) Q1 2024 Earnings Call Transcript May 9, 2024 Collegium Pharmaceutical, Inc.

NRXP has partnered with Alvogen Pharmaceuticals around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression. NRX-101 additionally has the potential to act as a ...

NRx Pharmaceuticals (Nasdaq: NRXP) recently shared its financials and offered updates on its business operations from the ...

Gutman has represented Alvogen Pine Brook, Amgen, Natco Pharma and Oxford Immunotec Global in prior patent fights. "Sige is regarded as one of the top life sciences patent litigators in the country," ...

Wessman also founded Alvogen, a contract manufacturing organization ("CMO") based in the US which went to become another generics drug company of renown. A biosimilar is a biological medicine that ...